| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |